<DOC>
	<DOCNO>NCT00549640</DOCNO>
	<brief_summary>Cigarette smoking continue major public health problem . Tobacco dependence intervention , recommend USPHS Clinical Practice Guideline effective smoker . A need exist new medication treat various aspect tobacco dependence , reinforce effect nicotine , relief nicotine withdrawal symptom prevention early relapse . The neurobiology effect methylphenidate similar reinforcing effect nicotine . In small previous study , methylphenidate report improve nicotine withdrawal symptom short term quit rate . Methylphenidate well tolerate , low abuse potential , less expensive compare tobacco dependence intervention . ConcertaTM , long act preparation methylphenidate , administer day , similar bioavailability generic drug administer 3 time day overall similar improve efficacy compare generic methylphenidate . We plan obtain preliminary efficacy data randomize , placebo-controlled phase II study assess effect methylphenidate cigarette smoker increase 7-day point prevalence smoking abstinence end treatment 7-day point prevalence prolong smoke abstinence 6-months . Critical systematic evaluation newer , innovative , well-tolerated treatment help treat tobacco use dependence provide wider choice therapeutic agent smoker wish become abstinent tobacco use .</brief_summary>
	<brief_title>Testing Methylphenidate Smoking Abstinence</brief_title>
	<detailed_description>Once enrol study , subject put one 2 group chance ( flip coin ) . They either receive methylphenidate placebo . Everyone study receive nicotine dependence counsel base intervention manual `` Smoke Free Living It '' . Everyone ask complete weekly study visit 8 week one follow-up phone call week 16 final study visit week 24 . The target quit day day visit 4 ( week 2 + 1 day ) . In first two week start study medication slowly build 3 pill day . For week 2 8 continue take 3 pill day .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Are 18 65 year age 2 . Have smoke cigarette daily past 6months currently smoke &gt; 10 cigarettes/day 3 . Are willing make attempt stop smoking 4 . Are able participate fully aspects study 5 . Have provide , understand , sign inform consent 1 . Have clinically significant level current depression assess CESD determine physician ; lifetime diagnosis bipolar disorder , schizophrenia dementia determine physician investigator 2 . Are currently ( previous 30 day ) use tobacco treatment program ( i.e. , behavioral therapy , nicotine replacement therapy , bupropion SR , varenicline , clonidine nortriptyline ) 3 . Have use investigational drug within 30 day prior enrol study 4 . Alcohol drug abuse dependence within past year assess study investigator use CAGE questionnaire Drug Abuse Screening Test 20 ( DAST20 ) 5 . Are pregnant , lactating , child bear potential , likely become pregnant medication phase willing use contraception . The following birth control measure acceptable : approve hormonal contraceptive medication device , approve intrauterine contraceptive device , use two combine barrier method ( diaphragm spermicide condom spermicide ) , birth control pill , injection , intrauterine device [ IUD ] , abstinence , surgical sterilization subject monogamous partner . 6 . Have history major cardiovascular event past 6months include unstable angina , acute MI coronary angioplasty 7 . Have clinically significant acute chronic , progressive unstable neurologic ( dementia , delirium seizure disorder ) , hepatic , renal , cardiovascular , respiratory metabolic disease would limit participation study 8 . Are currently follow prescribe medication know interact methylphenidate able stop medication study period : stimulant , warfarin , anticonvulsant , antidepressant , antipsychotic , monoamine oxidase inhibitor , clonidine , theophylline pseudoephedrine 9 . Uncontrolled hypertension ( &gt; 160/100 ) tachycardia ( Heart rate &gt; 110 ) 10 . Have another household member relative participating study 11 . Have know allergy methylphenidate constituent 12 . Have specific medical condition use methylphenidate contraindicate : narrow angle glaucoma , motor tic , family history diagnosis Tourette 's syndrome , history GI obstruction ( include history stricture , adhesion , abdominal surgery ) 13. ECG significant arrhythmia abnormal conduction , opinion physician investigator preclude participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>nicotine dependence</keyword>
	<keyword>tobacco dependence</keyword>
</DOC>